Gilead Sciences Inc (NASDAQ:GILD)

Thursday’s Trading Day
111.22 +1.05 / +0.95%
As of May 21
Day’s Change
Friday’s Pre-Market   Switch to standard view »
111.44 +0.22 / +0.20%
 
Volume: 300.00
J&J (JNJ) to File for More than 10 New Products by 2019 - Analyst Blog
May 21 / Zacks.com
Merck KGaA Q1 Earnings Fall Y/Y, 2015 Sales View Retained - Analyst Blog
May 19 / Zacks.com
Johnson & Johnson Just Stepped Up Its Hepatitis C Game
May 21 / MotleyFool.com
Stock Market News for May 19, 2015 - Market News
May 19 / Zacks.com
Bristol-Myers' HCV Combination Designation Amended by FDA - Analyst Blog
May 21 / Zacks.com
Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon
May 19 / TheStreet.com
MannKind, Front and Center: The Best Product Doesnbt Always Equal the Best Stock
May 21 / MotleyFool.com
Eleven Biotherapeutics (EBIO) in Focus: Stock Tanks 69.2% - Tale of the Tape
May 19 / Zacks.com
Following Hepatitis C, This Could Be the Next Disease Researchers Cure
May 21 / MotleyFool.com
3 Best Biotech Stocks to Add to Your Portfolio
May 19 / TheStreet.com
Johnson & Johnson Takes On Gilead Sciences in Hep C... Again
May 20 / MotleyFool.com
Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest
May 19 / TheStreet.com
Intercept Pharmaceuticals Reveals Phase III OCA Study Plan - Analyst Blog
May 20 / Zacks.com
The Best Blue Chips to Own Forever
May 18 / MotleyFool.com
Achillion and Johnson & Johnson in $1.1B HCV Tie-Up - Analyst Blog
May 20 / Zacks.com
Alnylam Files Clinical Trial Application for ALN-AAT - Analyst Blog
May 18 / Zacks.com
Why Achillion Pharmaceuticals, Inc. Shares Are Collapsing
May 20 / MotleyFool.com
Why Achillion Pharmaceuticals, Inc. Shares Soared Today
May 18 / MotleyFool.com
America's 10 fastest-growing big companies
May 20 / CNNMoney.com
3 Biotechs That Are Worth Buying
May 18 / TheStreet.com
5 NASDAQ Healthcare Stocks With The Highest EPS
May 20 / Benzinga
Kite Pharma Narrows Q1 Loss, Misses Estimates; Gives View - Analyst Blog
May 18 / Zacks.com
Zacks.com featured expert Kevin Matras highlights: Outerwall, Gilead Sciences, Lionbr...
May 20 / Zacks.com
Gilead Sciences (GILD) Stock: 3 Reasons Why It Is a Top Choice for Growth Investors -...
May 18 / Zacks.com
SWOT Analysis of Gilead Sciences Inc. Stock
May 20 / MotleyFool.com
This Experimental Drug Could Finally Cure HIV
May 18 / MotleyFool.com
10 S&P 500 Companies to Have the Most Revenue Growth in 2015
May 20 / TheStreet.com
3 Types of Risks Facing Biotech Stocks
May 18 / MotleyFool.com
Intercept Pharmaceuticals (ICPT) in Focus: Stock Tanks 16.1% - Tale of the Tape
May 20 / Zacks.com
Celgene, Gilead, Netflix, Costco: Jim Cramer's Views
May 18 / TheStreet.com
How Celgene Stock Is Breaking All the Rules
May 20 / MotleyFool.com
Is Gilead Sciences Its Own Worst Enemy?
May 17 / MotleyFool.com
Endo to Acquire Par Pharma for $8.05B, Shares Down - Analyst Blog
May 19 / Zacks.com
3 Safe Investments in Biotech (Relatively Speaking)
May 17 / MotleyFool.com
Regeneron/Sanofi Announce Positive Data on Dupilumab - Analyst Blog
May 19 / Zacks.com
Could an HIV/AIDS Vaccine Be a Reality By the End of the Decade?
May 16 / MotleyFool.com
Eleven Biotherapeutics Tanks after Eye Drug Fails Study - Analyst Blog
May 19 / Zacks.com
Could This Tiny Biotech Be on Gilead Sciencesb M&A Radar?
May 16 / MotleyFool.com
Theravance Biopharma Posts Positive Data on Velusetrag - Analyst Blog
May 19 / Zacks.com
Amgen Announces Positive Results on Migraine Candidate - Analyst Blog
May 15 / Zacks.com
Genomic Health's Loss Lingers, Profits Expected in 4Q15 - Analyst Blog
May 19 / Zacks.com
Agenus (AGEN) Provides Update on its Brain Cancer Vaccine - Analyst Blog
May 15 / Zacks.com
XBiotech's Xilonix Recommended for Colorectal Cancer Study - Analyst Blog
May 19 / Zacks.com
Endo/BioDelivery Reveal Encouraging Data on Pain Drug - Analyst Blog
May 15 / Zacks.com
Lannett (LCI) Signs Deal to Acquire Silarx Pharmaceuticals - Analyst Blog
May 19 / Zacks.com
Corcept Therapeutics' Korlym Positive in Breast Cancer Study - Analyst Blog
May 15 / Zacks.com
Celgene/Accelreon's Luspatercept Granted Fast Track Status - Analyst Blog
May 19 / Zacks.com
Teva Presents Encouraging Data from Chronic Migraine Study - Analyst Blog
May 15 / Zacks.com
Apple, Gilead, JPMorgan Look Cheap
May 19 / TheStreet.com
Eli Lilly, Sanford-Burnham Ink Deal for Immunotherapies - Analyst Blog
May 15 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account